Analysis of the humoral and cell-mediated immune response in heterologous and homologous SARS-CoV-2 revaccination
The effectiveness of humoral and cell-mediated immunity as a result of primary vaccination for Severe Acute Respiratory Syndrome- related CoronaVirus 2 (SARS-CoV-2), as well as the effectiveness of revaccination, is an important research problem. Studying and selecting optimal revaccination regimens...
Saved in:
Main Authors: | O. M. Drapkina, M. G. Chashchin, S. A. Berns, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova, O. A. Litinskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2023-11-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3764 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 incidence after vaccination with different types of vaccines against SARS-CoV-2
by: O. M. Drapkina, et al.
Published: (2025-02-01) -
Severity and duration of immune response in people of different age categories after SARS-CoV-2 revaccination
by: O. M. Drapkina, et al.
Published: (2023-12-01) -
Comparative assessment of the immunogenicity of various revaccination regimens against the SARS-CoV-2
by: O. M. Drapkina, et al.
Published: (2023-01-01) -
Long-term dynamics of the levels of anti-SARS-CoV-2 S-protein IgG antibodies in vaccinated individuals
by: O. M. Drapkina, et al.
Published: (2022-01-01) -
Incidence of COVID-19 among Vaccinated with Sputnik V and CoviVac Vaccines (Results of the Telephone Survey for the Epidemic Season 2021–2022 in St. Petersburg)
by: M. K. Erofeeva, et al.
Published: (2024-01-01)